Jennifer A. Sandberg

Author

National Center for Toxicological Research

Also Known As

J A Sandberg, J. A. Sandberg, J.A. Sandberg, JENNIFER A. SANDBERG, Janette Sandberg, Jennifer A Sandberg, Jennifer A Sandberg Helen M Duhart, Jennifer A. Sandberg

Publications

923

Citations

H-Index

Concepts

All Affiliations

National Center for Toxicological Research Nivalis Therapeutics (United States)Oregon Health & Science University Center for Food Safety and Applied Nutrition Cleveland Clinic

About

Jennifer A. Sandberg is an author at National Center for Toxicological Research specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	701
2	Engineering	2	2	43
3	Health Sciences	2	2	356
4	Social Sciences	2	2	41
5	Public Health	1	1	12

Jennifer A. Sandberg

Publications

872

Citations

H-Index

Page 1

	Year	Citations
Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group. Barry F. Uretsky, Mariell Jessup, M A Konstam, Circulation Heart FailureMulticenter Trial GroupCardiovascular PharmacologyPlacebo-controlled TrialPharmacotherapy	1990	324
Pharmacokinetics and tolerability of an antiangiogenic ribozyme (ANGIOZYME) in healthy volunteers. Jennifer A. Sandberg, Vann P. Parker, Karin S. Blanchard, PubMed Ribozyme AdministrationPharmacological StudyClinical TherapeuticMedicineHealthy Volunteers	2000	51
Pharmacokinetics and Tissue Distribution of a Ribozyme Directed Against Hepatitis C Virus RNA Following Subcutaneous or Intravenous Administration in Mice Patrice A. Lee, Lawrence M. Blatt, Karin S. Blanchard, Hepatology	2000	49
Pharmacokinetics of an Antiangiogenic Ribozyme (ANGIOZYME™) in the Mouse Jennifer A. Sandberg, Karyn Bouhana, Adalberto M. Gallegos, Antisense and Nucleic Acid Drug Development Extravascular InjectionsTranslational MedicineOncologyAngiogenesisGrowth Factor	1999	44
Pharmacokinetics and Tolerability of an Antiangiogenic Ribozyme (ANGIOZYME™) in Healthy Volunteers Jennifer A. Sandberg, Vann P. Parker, Karin S. Blanchard, The Journal of Clinical Pharmacology Molecular PharmacologyTherapeutic Drug MonitoringPharmacokinetic ModelingCardiovascular DiseaseClinical Therapeutic	2000	44
Microassay for the simultaneous determination of cocaine, norcocaine, benzoylecgonine and benzoylnorecgonine by high-performance liquid chromatography Jennifer A. Sandberg, George D. Olsen Journal of Chromatography B Biomedical Sciences and Applications Gas ChromatographyMedicineBioanalysisForensic ToxicologyDrug Test	1990	34
Transplacental pharmacokinetics and fetal distribution of azidothymidine, its glucuronide, and phosphorylated metabolites in late-term rhesus macaques after maternal infusion. Tucker A. Patterson, Zbigniew Binienda, George W. Lipe, PubMed Maternal ImmunizationTranslational MedicineMaternal InfusionMedicineTransplacental Pharmacokinetics	1997	33
Construction of a Physiologically Based Pharmacokinetic Model for 2,4-Dichlorophenoxyacetic Acid Dosimetry in the Developing Rabbit Brain C.S. Kim, Zbigniew Binienda, Jennifer A. Sandberg Toxicology and Applied Pharmacology Developing Rabbit BrainPharmacokinetic ModelingPhysiologically-based Pharmacokinetic ModelingPharmacological StudyMedicine	1996	32
Acute Toxicology and Pharmacokinetic Assessment of a Ribozyme (ANGIOZYME™) Targeting Vascular Endothelial Growth Factor Receptor mRNA in the Cynomolgus Monkey Jennifer A. Sandberg, Christopher D. Sproul, Karin S. Blanchard, Antisense and Nucleic Acid Drug Development ThrombosisAngiogenesisAcute ToxicologyCardiovascular DiseaseVascular Pharmacology	2000	30
The encapsulation of ribozymes in biodegradable polymeric matrices John K. Jackson, Linda S. Liang, William L. Hunter, International Journal of Pharmaceutics EngineeringNatural PolymerPolymer ScienceBiodegradable Polymeric MatricesPolymer Chemistry	2002	28

Page 1